Filing Details
- Accession Number:
- 0001209191-18-001466
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-03 19:25:45
- Reporting Period:
- 2018-01-01
- Accepted Time:
- 2018-01-03 19:25:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879407 | Arrowhead Pharmaceuticals Inc. | ARWR | Pharmaceutical Preparations (2834) | 460408024 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1219384 | D Bruce Given | 225 S. Lake Avenue Suite 1050 Pasadena CA 91101 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-01 | 175,000 | $0.00 | 948,356 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2018-01-01 | 20,000 | $3.69 | 928,356 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents shares underlying a restricted stock unit, which shares will vest in four equal annual installments.
- Open market sale pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The sale was made to generate proceeds to cover the tax liability incident to the vesting of restricted stock units on 01/01/2018.
Billionaire Hedge Funds
